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Abstract
Botulinum neurotoxins (BoNT/A-G) are well-known to act by blocking synaptic vesicle
exocytosis. Whether BoNTs disrupt additional neuronal functions has not been addressed. Here
we report that cleavage of syntaxin 1 (Syx 1) by BoNT/C and cleavage of SNAP-25 by BoNT/E
both induce degeneration of cultured rodent and human neurons. Furthermore, although SNAP-25
cleaved by BoNT/A can still support neuron survival, it has reduced capacity to tolerate additional
mutations and also fails to pair with syntaxin isoforms other than Syx 1. Syx 1 and SNAP-25 are
well-known for mediating synaptic vesicle exocytosis, but we found that neuronal death is due to
blockage of plasma membrane recycling processes that share Syx 1/SNAP-25 for exocytosis,
independent of blockage of synaptic vesicle exocytosis. These findings reveal neuronal
cytotoxicity for a subset of BoNTs and directly link Syx 1/SNAP-25 to neuron survival as the
prevalent SNARE proteins mediating multiple fusion events on neuronal plasma membranes.
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tIntroduction
Botulinum neurotoxins (BoNTs) are the most potent toxins known to humans and are one of
the six highest-risk bioterrorism agents 1,2. These toxins are produced by anaerobic
Clostridium bacteria and include seven serotypes (BoNT/A-G). BoNTs are composed of a
light chain (LC, ~50 kDa) and a heavy chain (HC, ~100 kDa) connected via a disulfide
bond. The HC contains a receptor binding domain that targets neurons and a membrane
translocation domain that translocates the LC into the cytosol. LCs act as proteases cleaving
proteins required for synaptic vesicle exocytosis 1,2.
Specifically, BoNT/B, D, F, and G cleave a vesicle protein synaptobrevin II (Syb). BoNT/A,
C, and E cleave a peripheral plasma membrane protein SNAP-25. BoNT/C also cleaves a
plasma membrane protein Syx 1 (Fig. 1a). These three toxin substrates form the core
complex essential for fusion of synaptic vesicle membranes to plasma membranes, known as
SNARE proteins (soluble NSF attachment protein receptor) 3. Cleavage of SNARE proteins
blocks synaptic vesicle exocytosis and paralyzes humans and animals.
BoNTs’ ability to block synaptic vesicle exocytosis is also the basis for their medical
applications: local injections of minute amounts of toxins can attenuate neuronal activities in
targeted regions, which can be beneficial in many medical conditions. The unprecedented
expansion of BoNTs in medical applications in recent years raises the pressing need to
understand whether BoNTs can disrupt additional functions beyond synaptic vesicle
exocytosis.
Indeed, it has been well documented that exposure to BoNT/C can cause degeneration of
neurons in vitro and in vivo in mice 4-9. If BoNTs only block synaptic vesicle exocytosis,
they should not affect neuron viability, as synaptic vesicle exocytosis is not required for
development and survival of neurons. For instance, tetanus neurotoxin, which blocks
synaptic vesicle exocytosis by cleaving Syb, does not affect survival of cultured
neurons 6,10. Furthermore, lacking the presynaptic protein Munc13 completely abolishes
synaptic vesicle exocytosis, yet Munc13 knock out (KO) mice develop normal brain
structures and neurons cultured from these mice grow normally in vitro 11. Therefore,
BoNT/C must disrupt additional functions in addition to blocking synaptic vesicle
exocytosis.
Why BoNT/C is toxic to neurons remains unknown, nor do we know whether any other
BoNTs can induce death of neurons. Here we sought to address which BoNTs induce
neurodegeneration, what toxin substrates are required for neuron survival, and what cellular
function via the action of BoNTs causes neurodegeneration. We found cytotoxicity for not
only BoNT/C, but also for BoNT/E, as well as a direct link between these toxins and Syx 1/
SNAP-25 in mediating multiple fusion events on neuronal plasma membranes that lead to
neurodegeneration.
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BoNT/C and E induce degeneration of cultured neurons
Using cultured rat hippocampal neurons as a model, we first developed an axon
fragmentation assay to visualize and quantify BoNT/C-induced neuronal death (Fig. 1b,
Supplementary Fig. S1). Axon fragmentation is detected via immunostaining of axon-
specific cytoskeleton protein neurofilament and the percentage of fragmented axons is
quantified using ImageJ software (Fig. 1b, Supplementary Fig. S1b). Consistent with
previous characterizations by Berliocchi et al 8, we found that sub-nanomolar levels of
BoNT/C induced fragmentation of both axons and dendrites, and subsequent apoptosis of
cell bodies, measured by multiple approaches (Supplementary Fig. S1).
Using the axon fragmentation assay, we first screened the other six BoNTs, which all can
enter hippocampal neurons and cleave their target SNARE proteins (Fig. 1c). Of the six
toxins screened, we found that BoNT/E induces axon degeneration and neuronal death (Fig.
1d, Supplementary Fig. S2). BoNTs that cleave Syb (BoNT/B, D, F, and G), as well as
BoNT/A, do not affect axons and survival of neurons (Fig. 1d), demonstrating that blocking
synaptic vesicle exocytosis is not the reason for neurodegeneration. Pre-incubation of
BoNT/C and BoNT/E with their respective antibodies prevented axon degeneration (Fig.
1e), confirming that it is BoNT/C and E in toxin solutions that induce degeneration of
neurons.
In addition to hippocampal neurons, BoNT/C and E also induced degeneration of cultured
rat motor neurons as well as human motor neurons derived from embryonic stem cells (Fig.
1f), demonstrating that these physiologically relevant target neurons are susceptible to
cytotoxicity of BoNT/C and E. The other five BoNTs did not cause degeneration of rat or
human motor neurons (Supplementary Fig. S3).
The BoNT/C and E protease domains induce death of neurons
We next examined whether cytotoxicity of BoNT/C and E is due to the protease activity of
their LCs (Fig. 2a). We expressed LCs of BoNT/C and E directly in neurons via lentiviral
transduction. BoNT/A-LC was also assayed as a control. These LCs cleaved their target
SNARE proteins in neurons (Fig. 2b). We found that both BoNT/C-LC and BoNT/E-LC
induced axon degeneration and neuron death (Fig. 2c), whereas BoNT/A-LC did not affect
neurons (Fig. 2c).
We further found that expressing LCs of BoNT/C and E in only a few neurons by
transfection resulted in degeneration of transfected neurons, suggesting that the cytotoxicity
of BoNT/C and E is cell-autonomous (Fig. 2d). The cytotoxicity is also likely specific to
neurons, as LCs of BoNT/C and E did not affect survival of Neuro-2A cells, a
neuroblastoma cell line that expresses Syx 1/SNAP-25, or primary glial cells
(Supplementary Fig. S4).
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We next sought to identify the toxin substrate proteins whose cleavage leads to
neurodegeneration. BoNT/C is known to cleave Syx 1 and SNAP-25 (Fig. 1a, 12-14).
Because BoNT/A cleaves one more residue from SNAP-25 than BoNT/C does (Fig. 1a), yet
BoNT/A does not induce degeneration of neurons (Fig. 1d, 2c), cleavage of SNAP-25 by
BoNT/C is not the reason for its cytotoxicity. Therefore, we focused on Syx 1, which has
two redundant isoforms, Syx 1A and 1B, in neurons. To test the role of Syx 1, we created
toxin-resistant mutants, designated as Syx 1A/CR (BoNT/C-resistant) and Syx 1B/CR, by
changing four residues at the toxin cleavage site. The same mutations were used to create a
mutant syntaxin 2 (Syx 2) as a control, which is one of the four plasma membrane Syx
family members (Syx 1-4) 3. These CR mutants are resistant to BoNT/C in neurons (Fig.
3a). We found that Syx 1A/CR and Syx 1B/CR, but not Syx 2/CR, fully prevented BoNT/C-
induced axon degeneration and neuron death (Fig. 3b, Supplementary Fig. S5a,c).
Furthermore, expression of these CR mutants did not affect cleavage of endogenous Syx 1
and SNAP-25 by BoNT/C (Fig. 3a, left panel), indicating that these toxin-resistant substrates
did not protect neurons by deactivating BoNT/C. Instead, they likely replaced endogenous
Syx 1. Together, these data demonstrate that cleavage of Syx 1 by BoNT/C causes
neurodegeneration.
Cleavage of SNAP-25 by BoNT/E causes degeneration of neurons
BoNT/E is known to cleave SNAP-25 (Fig. 1a, 15,16). We next created a BoNT/E resistant
SNAP-25 mutant, designated as SNAP-25/ER, by replacing four residues at the BoNT/E
cleavage site (Fig. 3c). We also used SNAP-23 as a control, which is the other SNAP-25
family member. SNAP-23 is expressed in non-neuronal cells and developing neurons 17, but
its expression in mature hippocampal neurons is not detectable (Fig. 3d, Supplementary Fig.
S6a). When expressed in neurons via lentiviral transduction, SNAP-23 was not cleaved by
nanomolar levels of BoNT/E added to media (Fig. 3d), despite that it contains the toxin
cleavage site and can be cleaved by high levels of BoNT/E-LC co-expressed in HEK293
cells (Supplementary Fig. S6b). These results indicate that SNAP-23 is not an effective
substrate for BoNT/E in neurons. This finding allows us to test whether wild type (WT)
SNAP-23 can prevent BoNT/E cytotoxicity.
We found that both SNAP-25/ER and WT SNAP-23 fully prevented BoNT/E-induced axon
degeneration and neuron death (Fig. 3e, Supplementary Fig. S5b,c), suggesting that
SNAP-25 and SNAP-23 are functionally redundant in supporting neuron survival.
Expression of these BoNT/E-resistant substrates did not affect cleavage of endogenous
SNAP-25 by BoNT/E (Fig. 3c,d), indicating that SNAP-25/ER and SNAP-23 protected
neurons by restoring essential cellular functions instead of deactivating BoNT/E. Because
SNAP-23 is not expressed in mature neurons and it is not cleaved by nanomolar BoNT/E,
we conclude that cleavage of endogenous SNAP-25 is the reason for BoNT/E-induced
neurodegeneration.
Consistent with our studies using active full-length toxins, co-transfecting toxin-resistant
Syx 1A/CR with BoNT/C-LC, and SNAP-25/ER or SNAP-23 with BoNT/E-LC,
respectively, prevented degeneration of transfected neurons (Supplementary Fig. S7). In
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taddition to hippocampal neurons, we found that Syx 1A/CR and SNAP-25/ER also rescued
rat motor neurons and human motor neurons from BoNT/C and E, respectively
(Supplementary Fig. S8). As it has been argued whether inhibitory neurons express
SNAP-25 18-20, we further examined the effect of BoNT/E on inhibitory neurons and found
that BoNT/E can induce degeneration of both excitatory and inhibitory neurons
(Supplementary Fig. S9). These data support that SNAP-25 is expressed in inhibitory
neurons.
Cytotoxicity requires cleavage of nearly all Syx 1/SNAP-25
We next titrated BoNT/C and E to determine the minimal toxin concentrations that can
induce degeneration of neurons. We found that BoNT/C at 10 pM and BoNT/E at 100 pM
are tolerated (Supplementary Fig. S10). We then examined the residual Syx 1/SNAP-25
levels after neurons were exposed to BoNT/C and E at these “safe” concentrations. We
found that BoNT/C at 10 pM eventually cleaved the majority of Syx 1 after five days (Fig.
3f). Syx 1 levels start to recover by day 6 (Fig. 3f), indicating that the toxin activity has
started to decrease after five days. Because BoNT/C at 10 pM does not induce
neurodegeneration, we conclude that the residue low level of Syx 1 at day 5 is still sufficient
to support neuron survival.
Similarly, we found that BoNT/E at 100 pM cleaved the majority of SNAP-25 by 24 hrs
(Fig. 3g). Because BoNT/E has a shorter half-life than BoNT/C in neurons 21, SNAP-25
starts to rise by 48 hrs after exposure to BoNT/E (Fig. 3g). Therefore, the residue low level
of SNAP-25 at 24 hrs after exposure to BoNT/E is still sufficient to support neuron survival.
To further confirm these conclusions, we used a different approach: knocking down (KD)
endogenous SNAP-25 using lentiviral-mediated shRNA (Fig. 3h). The expression of
SNAP-25 was reduced significantly (Fig. 3h, left panel), yet we did not observe axon
fragmentation and neurodegeneration (Fig. 3h, right panel), suggesting that the residue level
of SNAP-25 is still sufficient. Therefore, we conclude that only a minute percentage of
endogenous Syx 1/SNAP-25 is needed to maintain neuron survival, and neurodegeneration
only occurs when nearly all Syx 1/SNAP-25 are cleaved by toxins.
BoNT/A-cleaved SNAP-25 doesn't tolerate additional mutations
The finding that SNAP-25 is required for neuron survival raises a question: why doesn't
BoNT/A induce neurodegeneration? The likely explanation is that BoNT/A only cleaves 9
amino acids, while BoNT/E cleaves 26 amino acids from the C-terminus of SNAP-25 (Fig.
4a) 1. To test this hypothesis directly, we constructed a SNAP-23 mutant that lacks the last 9
amino acids. We used human SNAP-23 instead of SNAP-25 since human SNAP-23 is
resistant to BoNT/E (Supplementary Fig. S6c). This allows us to avoid the inclusion of
additional mutations at the BoNT/E cleavage site (an issue discussed further below). We
found that this truncated SNAP-23 mutant can support neuron survival when endogenous
SNAP-25 was abolished by BoNT/E (Fig. 4b).
The next question is whether BoNT/A-cleavage attenuates the function of SNAP-25. One
way to determine this is to introduce additional mutations to SNAP-25. If loss of the last 9
amino acids weakens the function of SNAP-25, additional mutations that are tolerated in
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effects.
In fact, we already have a “perfect” SNAP-25 mutant for this experiment: SNAP-25/ER
mutant (Fig. 3c, e). This mutant can fully rescue neurons from BoNT/E, demonstrating that
the mutations in it are tolerated in full-length SNAP-25. To determine whether SNAP-25/ER
can afford to lose the last 9 amino acids, we exposed neurons expressing SNAP-25/ER to
both BoNT/E and BoNT/A. BoNT/E cleaved endogenous SNAP-25, virtually creating
neurons that expressed only SNAP-25/ER. We found that cleavage of SNAP-25/ER by
BoNT/A in these neurons induced death of neurons (Fig. 4c-e). These results demonstrate
that SNAP-25 cleaved by BoNT/A has a reduced capacity to tolerate additional mutations.
Syx 1/SNAP-25 act as SNARE proteins for neuron survival
We next sought to determine whether Syx 1/SNAP-25 needs to form functional SNARE
complexes for maintaining neuron survival. The pairing interfaces (layers −7 to +8) of Syx 1
and SNAP-25 in SNARE complexes have been well established 3,22,23. We first examined
two well-characterized point mutations in the SNARE interfaces: Syx 1 (A240V, V244A)
and SNAP-25 (M71A). Both mutants lose the ability to mediate vesicle exocytosis 24-26.
When expressed in neurons via lentiviral transduction, these two mutants also failed to
prevent toxin-induced degeneration of neurons, respectively (Fig. 5a, b).
We further examined whether there are additive effects between mutations in the same layer
in Syx 1 and SNAP-25. To do so, we mutated residues at layers +1/−1 to alanines in both
Syx 1A/CR and SNAP-23 (Fig. 5c). SNAP-23 was used to avoid additional mutations at the
BoNT/E cleavage site. Syx 1A/CR(+1/−1) mutant prevented axon degeneration induced by
BoNT/C, and SNAP-23(+1/−1) prevented axon degeneration induced by BoNT/E (Fig. 5d).
However, when Syx 1A/CR(+1/−1) and SNAP-23(+1/−1) were expressed together, they
failed to prevent axon degeneration in the presence of both BoNT/C and E (Fig. 5d). The
likely explanation is that mutations at +1/−1 layers in Syx 1A and SNAP-23 are tolerated
when pairing with endogenous WT partners, but they cannot form functional SNARE
complexes with each other when endogenous WT SNAREs are eliminated with toxins. This
additive effect demonstrates that Syx 1 and SNAP-25/23 need to pair with each other as
SNARE proteins to support neuron survival.
Other homologous SNARE pairs can support neuron survival
In addition to mediating membrane fusion, Syx 1 and SNAP-25 have also been reported to
interact with and regulate various ion channels 20,27-29. The membrane fusion function is
shared by other homologous plasma membrane SNARE proteins, namely Syx 2/3/4 for Syx
1 and SNAP-23 for SNAP-25 (Fig. 6a), whereas interactions with ion channels are often
specific to Syx 1/SNAP-25. To further distinguish the role of Syx 1/SNAP-25, we next
examined whether Syx1 can be substituted by Syx 2/3/4. Similar to SNAP-23, we found that
Syx 2, 3, and 4 are not expressed at detectable levels in mature hippocampal neurons (Fig.
6b-d). When expressed exogenously via lentiviral transduction, Syx 2 and 3 were not
cleaved by sub-nanomolar levels of BoNT/C (Fig. 6b, c), despite containing the BoNT/C
cleavage sites. These findings indicate that Syx 2/3 are not effective substrates for BoNT/C
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tin neurons. Syx 4 is known to be resistant to BoNT/C 13 (Fig. 6d). Despite being resistant to
BoNT/C, we found that WT Syx 2/3/4 all failed to prevent BoNT/C-induced axon
degeneration (Fig. 6e).
We next considered the possibility that the reason Syx 2/3/4 failed to rescue neurons from
BoNT/C is because BoNT/C also cleaves SNAP-25 and truncates 8 residues from its C-
terminus (Fig. 4a). We used two different approaches to address this issue. First, we
circumvented it by expressing exogenous SNAP-23 in neurons, which is resistant to
BoNT/C (Supplementary Fig. S6b) 30. We found that co-expressing SNAP-23 with Syx
2/3/4 prevented BoNT/C-induced axon degeneration (Fig. 6f). Thus, the Syx 1/SNAP-25
pair can be replaced by exogenous pairs of Syx 2/3/4 with SNAP-23, which are plasma
membrane SNARE pairs commonly found in non-neuronal cells.
Second, we utilized a newly created mutant BoNT/C-LC (BoNT/C-α51) that only cleaves
Syx 1, but loses the ability to cleave SNAP-25 (Fig. 6g) 31. As expected, BoNT/C-α51
cleaved Syx 1 and still induced axon degeneration in neurons (Fig. 6h). Co-expressing
exogenous Syx 2/3/4 in neurons prevented neurodegeneration induced by BoNT/C-α51,
without the need to express SNAP-23 (Fig. 6h). These results demonstrate that Syx 2/3/4
can pair with full-length SNAP-25 to support neuron survival. Therefore, all possible
combinations of known plasma membrane SNARE proteins, one from the Syx family, one
from SNAP-25/23, can be used to support neuron survival. These findings demonstrate that
the function of Syx 1/SNAP-25 for neuron survival depends on their intrinsic property as
SNARE proteins for membrane fusion.
SNAP-25 cleaved by BoNT/A cannot pair with Syx 2/3/4
As BoNT/A cleaves one more residue from SNAP-25 than BoNT/C, we expect that Syx
2/3/4 will not be able to pair with SNAP-25 cleaved by BoNT/A. To directly examine this
possibility, we abolished Syx 1 in hippocampal neurons with BoNT/C-α51 while co-
expressing Syx 2/3/4, virtually creating neurons that express Syx 2/3/4 instead of Syx 1. We
found that BoNT/A readily induced axon degeneration in these neurons that rely on Syx
2/3/4 (Fig. 6i). Thus, the safety of BoNT/A depends on specific plasma membrane SNARE
isoforms expressed in target neurons.
Cytotoxicity is independent of synaptic vesicle exocytosis
There are three major membrane fusion events at plasma membranes: (1) regulated vesicle
exocytosis such as synaptic vesicle release; (2) constitutive exocytosis/secretion; (3)
exocytosis of plasma membrane recycling. We next examined which of these three routes is
involved in toxin-induced neurodegeneration.
We first further examined regulated synaptic vesicle exocytosis via sensitive
electrophysiological recording of miniature excitatory postsynaptic currents (mEPSCs) (Fig.
7a). We confirmed that BoNT/A blocked synaptic vesicle exocytosis and abolished mEPSCs
(Fig. 7a), yet it does not induce neurodegeneration (Fig. 1d, 2c). Furthermore, Syx 1A/CR
and SNAP-25/ER both failed to restore mEPSCs in neurons (Fig. 7a), despite their ability to
prevent toxin-induced neurodegeneration.
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tWe also examined stimulated synaptic vesicle exocytosis by depolarizing neurons with high
K+ buffers, and monitoring synaptic vesicle exocytosis using an antibody against the luminal
domain of the major vesicle protein synaptotagmin I (Syt I, Syt IN Ab, Fig. 7b). We found
that Syx 1A/CR and SNAP-25/ER both failed to restore binding and uptake of Syt IN Ab in
the presence of BoNT/C or E, respectively (Fig. 7b). Therefore, these toxin-resistant mutants
separate two functions of Syx 1 and SNAP-25: they can support neuron survival, but cannot
mediate synaptic vesicle exocytosis.
BoNT/C and E do not affect constitutive exocytosis
We next adopted a secreted Gaussia luciferase (Gluc) assay to test whether BoNT/C and E
block constitutive exocytosis/secretion in neurons. Gluc possesses a natural secretory signal.
Once expressed in neurons via lentiviral transduction, Gluc is released into media in a linear
increase over time (Fig. 7c). Furthermore, Gluc release is fully blocked by brefeldin A
(BFA), a potent blocker that disrupts secretory vesicle biogenesis (Fig. 7c), confirming that
Gluc is released via constitutive secretion in neurons.
By measuring Gluc levels in media, we found that BoNT/A, C, and E did not affect Gluc
secretion (Fig. 7d), indicating that these BoNTs do not disrupt constitutive exocytosis/
secretion. Furthermore, blocking constitutive exocytosis/secretion using BFA did not induce
axon fragmentation at the time point (36 hrs) when BoNT/C and E already induced severe
axon fragmentation (Fig. 7e). Thus, constitutive exocytosis/secretion is not involved in
toxin-induced neurodegeneration.
Blocking endocytosis delays degeneration of neurons
The third event is the exocytosis step during plasma membrane recycling processes. We
reasoned that if cleavage of Syx 1 and SNAP-25 disrupts recycling processes by blocking
the exocytosis step, blocking endocytosis may forcefully restore the balance at the plasma
membrane temporarily. We first blocked clathrin-mediated endocytosis using dominant
negative AP180 (AP180-C) or EPS15 (EPS15-DIII) 32, but both failed to affect the
degeneration of neurons (Fig.7f, Supplementary Fig. S11). We then blocked a broad range
of endocytosis including both clathrin-dependent and clathrin-independent endocytosis
using a dominant negative dynamin (K44A) 32. We found that dynamin (K44A)
significantly delayed degeneration of neurons induced by co-expressed BoNT/C-LC (Fig.
7f). As dynamin (K44A) did not affect cleavage of Syx 1 by BoNT/C in cells (Fig. 7g), it is
likely that blockage of endocytosis temporarily compensated the defects in exocytosis of
plasma membrane recycling processes. Thus, these data suggest that BoNT/C and E induce
neurodegeneration by disrupting exocytosis of essential dynamin-dependent recycling
processes.
Discussion
Our studies expanded the previous observations on BoNT/C cytotoxicity and revealed
BoNT/E as the second BoNT with cytotoxicity to neurons. We found that cytotoxicity only
occurs when toxins can effectively cleave the majority of Syx 1 or SNAP-25 in neurons,
indicating that only a small percentage of endogenous Syx 1/SNAP-25 is needed for
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tsupporting neuron survival. We estimated that the threshold concentrations for cytotoxicity
to occur are above 10 pM for BoNT/C and 100 pM for BoNT/E in cultured hippocampal
neurons. These concentrations are far higher than the lethal dose in humans and animals,
which is usually below femtomolar levels. Therefore, it is not likely cytotoxicity plays a
significant role in pathogenesis of BoNT/C and E. On the other hand, BoNTs are used to
target neurons locally via injections in therapeutic applications, and the same neurons are
often exposed to BoNTs repeatedly over a long period of time. Because of this sustained
toxin exposure, precautions should be taken in the use of BoNT/C and E as therapeutic
toxins.
Our studies establish that Syx 1/SNAP-25 are directly required for neuronal survival as the
plasma membrane SNAREs for membrane recycling, independent of their well-known role
for synaptic vesicle exocytosis. The specific cognate vesicle SNARE (v-SNARE) protein
mediating essential membrane recycling processes remains to be identified. We expect it to
be different from Syb, since BoNT/B, D, F, and G that cleave Syb do not induce
degeneration of neurons (Fig. 1d).
The findings that exogenous SNAP-23 alone (Fig. 6f), or Syx 2/3/4 alone (Fig. 6e), both
failed to prevent BoNT/C-induced degeneration of neurons, provide a functional readout
suggesting that there is no significant endogenous Syx 2/3/4 and SNAP-23 expression in
mature hippocampal neurons. Thus, Syx 1/SNAP-25 are the predominant, if not the only,
plasma membrane SNAREs and may act as promiscuous acceptors on plasma membranes in
mature neurons. By limiting the expression to only Syx 1/SNAP-25, mature neurons may
avoid potential interferences on neurotransmission from homologous SNARE proteins such
as SNAP-23 that cannot support fast synaptic vesicle exocytosis 18. This model is further
supported by previous findings that Syx 1/SNAP-25 are broadly distributed along neuronal
surfaces 33-35. This model also predicts that Syx 1/SNAP-25 may act as t-SNAREs for
recycling of possibly all postsynaptic receptors and surface proteins in mature hippocampal
neurons. This is supported by previous findings that SNAP-25 mediates protein kinase C
enhanced insertion of NMDA receptors and trafficking of kainate receptors 35,36.
Consistent with our conclusions that Syx 1/SNAP-25 are essential to neuron survival, it has
been reported that hippocampal neurons cultured from SNAP-25 KO mice degenerate
gradually in vitro 18,37, which can be rescued by expressing SNAP-25, SNAP-23, or a
SNAP-25 truncation lacking the nine residues at the C-terminus 18,38. Interestingly,
SNAP-25 KO neurons can sustain the first few days of growth in vitro. This is likely
because SNAP-23 is still expressed in developing neurons and its expression stops as
neurons become mature (Supplementary Fig. S6a). The compensation from SNAP-23 also
explains why the brain of SNAP-25 KO mice can develop normally until embryonic day 18
in vivo 37, and stochastic expression of SNAP-23 may explain why a tiny percentage of
SNAP-25 KO neurons (1.3%) can still survive for over 14 days in culture 18.
Syx 1 A/B double KO mice have not been generated since Syx 1 might be essential for
embryonic viability 39-42. Genetic studies in Drosophila have shown that Syx may mediate
multiple membrane fusion events in different cells throughout development, including
essential embryonic cellularization 40-42. Furthermore, genetic mosaic analysis in
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tDrosophila has demonstrated that lacking Syx causes cell lethality 43. It is also interesting to
note that lack of Munc-18, a Syx binding protein essential for SNARE mediated vesicle
exocytosis in cells 44, results in cell-autonomous degeneration of neurons 45. Thus, it is
likely Munc-18 is also required for exocytosis in plasma membrane recycling processes.
This is consistent with the hypothesis that both SNARE and SM (Sec1/Munc18 like)
proteins are required to form the minimal machinery for membrane fusion in cells 46.
Defects in CSPα, which is a co-chaperone for maintaining the SNAP-25 folding and
facilitating SNARE complex assembly 47,48, have been linked to neurodegenerative
diseases 49. In addition, α-synuclein may also act as a non-enzymatic chaperone to facilitate
SNARE assembly 50. Finally, changes of SNARE protein expression levels have been
reported in Alzheimer's disease and Huntington's disease 51-53. Our data establish a direct
role for Syx 1/SNAP-25 in supporting neuron survival and suggest that disruption of house-
keeping plasma membrane recycling processes might be a contributing factor in SNARE-
related neurodegenerative processes.
Methods
Antibodies and toxins
Mouse monoclonal antibodies for Syx 1 (HPC-1), SNAP-25 (C171.2), Syb (C169.1), Syt I
(Syt IN Ab, Cl604.4) were generously provided by E. Chapman (Madison, WI). Rabbit
polyclonal anti-BoNT/C and E were generated in E. Johnson's lab (Madison, WI). The
following antibodies were purchased from indicated vendors: mouse monoclonal antibodies
for axonal neurofilament (SMI312, Covance), actin (AC-15, Sigma-Aldrich), HA (16B12,
Covance), NeuN (Millipore), ChAT (AB144P, Millipore), GAD67 (1G10.2, Millipore);
rabbit polyclonal antibodies against SNAP-23, Syx 2, Syx 4 (Synaptic Systems), synapsin,
MAP-2 (Millipore); goat polyclonal antibody for Syx 3 (SC-47436, Santa Cruz).
BoNT/A (Hall-A), BoNT/B (Okra), BoNT/C (Brazil), BoNT/D (D1873), BoNT/E (Alaska),
and BoNT/F (Langeland) were purified in E. Johnson's lab from the indicated strains.
BoNT/G (G89) was purchased from Metabiologics (Madison, WI). The working
concentrations in culture media are: BoNT/A (10 nM), BoNT/B (20 nM), BoNT/C (0.3 nM),
BoNT/D (1 nM), BoNT/E (3 nM), BoNT/F (10 nM), BoNT/G (20 nM), unless otherwise
specified in the Figure Legends.
cDNA and Constructs
The following cDNAs were generously provided by the indicated groups: human SNAP-23
(P. Roche, NIH) 17, dynamin WT and K44A (S. Schmid, La Jolla, CA), AP180-C (L.
Greene, NIH), EPS15-DIII (A. Benmerah, France). The cDNA encoding LCs of BoNT/A
(residues 1-448, M30196), C (residues 1-449, X53751), D (residues 1-445, AB012112), E
(residues 1-422, X62683) were synthesized by GenScript (New Brunswick, NJ) with codon
optimized for eukaryotic cell expression. The cDNA encoding Gaussia luciferase (Gluc)
was purchased from NEB (Ipswich, MA).
Syx 1A/CR, 1B/CR, 2/CR were generated by replacing residues at P2P1P1’P2’ of the
BoNT/C cleavage site (KKAV in Syx 1A/1B, KKAI in Syx 2), with corresponding residues
Peng et al. Page 10
Nat Commun. Author manuscript; available in PMC 2014 June 11.
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
tin syntaxin 5 (LIYF). SNAP-25/ER was generated by replacing residues at P3P2P1P1’ of
the BoNT/E cleavage site (IDRI) in rat SNAP-25B with residues “NARE”. Other point
mutations and deletions are specified in the Figure Legends. All constructs were sub-cloned
into Lox-Syn-Syn lentiviral vectors, which contain two separate neuronal specific synapsin
promoters. For constructs expressing toxin LCs, DsRed was co-expressed by the second
synapsin promoter. For all other constructs, GFP was co-expressed. In Supplementary Fig.
S4 and S6b, toxin LCs were sub-cloned into pcDNA3.1 vector with CMV promoters for
over-expression in non-neuronal cells.
Primary neuron and glial cell culture
Dissociated rat hippocampal neurons were prepared from E18-19 embryos using a papain
dissociation kit (Worthington Biochemical, NJ), as described previously 54. Experiments
were carried out using mature neurons after DIV 14 days (days in vitro), unless otherwise
indicated in the Figure Legends.
Rat motor neurons were prepared from ventral spinal cords of E13 rats and dissociated with
papain. Dissociated cells were loaded on the top of 7.05% NycoPrep (Accurate Chemical,
NY) solutions and centrifuged (500 g, 20 min). Cells on the top of the solution were
collected, re-suspended in a 3 ml Neurobasal medium, and centrifuged (300 g, 5 min). Cell
pellets were re-suspended and plated on Poly-D-lysine coated coverslips with a mono-layer
of glial cells as described in detail below, at a density of 4 × 104 cells/well (24-well plate).
Motor neurons were grown in a Neurobasal medium containing B27 supplement
(Invitrogen) under 7% CO2.
Glial cells were isolated from postnatal day 1 (P1) rat brain. Meninges were removed; cells
were dissociated with trypsin (0.25%, 30 min) and cultured in the cell culture media
(DMEM, 10% FBS, 2 mM glutamine, and 1% penicillin/streptomycin). After 7-9 days, cells
were dissociated again with trypsin and plated onto coverslips at 20% confluence in the cell
culture media. Arabinofuranosylcytosine (Ara-C) was added to the media when the cells
reached 100% confluence to inhibit cell proliferation.
Transfection and lentiviral transduction
Transfection of neurons was performed between DIV8 to DIV12 using the calcium
phosphate method. HEK 293 cells and a mouse neuroblastoma cell line Neuro-2A were
transfected using Lipofectamine 2000 (Invitrogen). Lentiviral particles were generated using
packaging vectors VSV-G and ∆8.9 as described previously 54. Viruses were added to
neurons at DIV5.
Axon immunostaining and axonal degeneration quantification
Culture neurons were fixed with 4% paraformaldehyde, permeabilized with 0.25% Triton
X-100, and subjected to immunostaining using an antibody specific for axonal
neurofilament (SMI 312, 1:1000). An Alexa-546 conjugated secondary antibody was usually
utilized since many constructs co-express GFP. Images were collected using a confocal
microscope (Leica TCS SP5; 40× oil objective, Zoom 2).
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tQuantification of axonal degeneration was carried out using ImageJ (NIH). Briefly, the axon
immunostaining images were first converted into 8-bit black/white images and inverted, so
axons display in black, then threshold was set to ~180. The total axonal area was determined
by measuring all pixels above threshold, including both intact and fragmented axons.
Degenerated axons were detected using the Particle Analyzer module in ImageJ, by defining
particle size between 10 to 500 pixels. This range of particle size covers the majority of
observed beads and fragments of axons. The total area of particles divided by the total area
of pixels is defined as the percentage of degenerated axons. Each experiment was repeated
three times. Error bars in all figures represent SEM.
Immunoblot analysis
Cells were washed and lysed with RIPA buffer (50 mM Tris, 1% NP40, 150 mM NaCl,
0.5% sodium deoxycholate, 0.1% SDS) plus a protease inhibitor cocktail (Sigma-Aldrich).
Lysates were centrifuged for 10 min at maximum speed using a microcentrifuge at 4°C.
Supernatants were subjected to SDS-PAG and immunoblot analysis using the enhanced
chemiluminescence (ECL) method (Pierce).
Quantifying the survival rate of transfected neurons
GFP was co-transfected with toxin LCs in neurons to assist cell morphology analysis.
Twenty-four hours after transfection, GFP positive neurons were counted as total transfected
neurons using an epifluorescence microscope (Olympus IX 51, 20× objective). Degenerated
neurons were identified by their round cell bodies and fragmented neurites.
Lentiviral-mediated shRNA KD of SNAP-25
SNAP-25 shRNA KD constructs were generated using the following primer: 5′-
TGCTTAAATCCAGTGATGCTTTCAAGAGAAGCATCACTGGATTTAAGCTTTTTTC
-3′ , targeting the base-pair 282 – 300 of rat SNAP-25. Annealed primers were cloned into
the lentiviral vector pLL3.7 using HpaI and XhoI sites. Expression of shRNA is driven by a
U6 promoter, while a separate CMV promoter drives the expression of EGFP. Lentiviruses
were added to neurons on DIV5. Experiments were carried out on DIV12-14.
Constitutive secretion of Gluc
Gluc was expressed in neurons via lentiviral transduction. The neurons were washed and 2
ml fresh media were added. Gluc secreted into the media was measured by taking 50 μl
media and subjecting it to a luciferase activity assay using a kit following the manufacturer's
instructions (NEB, Ipswich, MA). To block constitutive secretion, cells were pre-treated
with BFA (1 μg/ml, Sigma-Aldrich) for 2 hrs before changing media and then further
incubated in the presence of BFA for the indicated times.
mEPSC recording
Whole-cell patch-clamp recordings were performed at ambient temperature using a
Multiclamp 700B amplifier (Molecular Devices). Cultured hippocampal neurons were
bathed with an external solution containing (in mM) 126 NaCl, 2.5 KCl, 2.5 CaCl2, 1.2
MgCl2, 25 NaHCO3, 1.2 NaH2PO4, and 11 D-glucose (pH 7.4, 300 mOsm). The patch
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telectrodes were filled with (in mM): 130 K-gluconate, 8 NaCl, 10 Hepes, 0.4 EGTA, 5
QX-314 (lidocaine N-ethyl bromide), 2 Mg-ATP, 0.25 GTP-Tris (pH 7.25). Miniature
EPSCs (mEPSCs) were recorded at the holding potential of −60 mV, with the presence of 1
μM TTX blocking action potentials, 50 μM D-AP5 (D-2-amino-5-phosphonopentanoate)
blocking NMDA receptors, and 100 μM picrotoxin blocking GABA receptors. Data were
analyzed with pClamp 10 (Molecular Devices) and Mini Analysis 6 (Synaptosoft). The
threshold for detecting mEPSC events was set at 9 pA.
Human motor neuron differentiation
Human embryonic stem cells (hESCs, lines H9, passages 19 to 35) were used to generate
neuroectodermal cells. Motor neuron induction was carried out as previously described 55.
Briefly, hESC–derived neuroectodermal cells were treated with retinoic acid (0.1 μM,
Sigma-Aldrich) for caudalization for one week in a chemically defined neural medium (NM:
DMEM/F12, nonessential amino acids, 2 μg/ml heparin, and the neural cell supplement N2
(Gibco)). The neuroepithelial clusters were isolated and suspended in the NM in the
presence of both retinoic acid and purmorphamine (1 μM, Calbiochem). Purmorphamine
was removed from the NM one week later. The formed progenitor spheres were
subsequently cultured on glass coverslips coated with polyornithine and laminin (2–4
clusters/coverslip in a 24-well plate) in the presence of 0.5 ml NM, supplemented with
BDNF (10 ng/ml; Peprotech), GDNF(10 ng/ml; R&D Systems), IGF1 (10 ng/ml;
Peprotech), cAMP (1 μM), ascorbic acid (200 ng/ml, Innovative Cell Technology), and 50
nM retinoic acid. Cell media were changed every other day for long term differentiation.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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tFigure 1. BoNT/C and E can induce degeneration of cultured rodent and human neurons
(a) Schematic drawings of the cleavage sites on neuronal SNAREs for the seven BoNTs.
BoNT/B, D, F, and G cleave Syb. BoNT/A and E cleave SNAP-25. BoNT/C cleaves both
Syx 1 and SNAP-25.
(b) Cultured rat hippocampal neurons were exposed to BoNT/C (0.3 nM, 48 hrs). Axons
were detected by immunostaining with an antibody specific for axonal neurofilament (SMI
312). Hippocampal neurons normally display continuous intact axons, while degenerated
axons show severe beading and fragmentation. The percentage of degenerated axons was
quantified (right panel), as described in Supplementary Fig. S1b. The same method was
utilized to assay axon degeneration in all applicable figures. Cultured rat hippocampal
neurons were used in all experiments, unless otherwise indicated in the Figure Legends.
Scale bars in all applicable panels represent 20 μm.
(c) Neurons were exposed to the seven BoNTs, respectively, for 12 hrs in media. Cell
lysates were harvested for immunoblot analysis detecting the indicated proteins. Actin
served as the internal control for loading. Cleavage of SNAP-25 by BoNT/A, C, and E
generated fragments with smaller molecular weight. The Syx 1 fragment generated by
BoNT/C was degraded within cells, resulting in multiple weak bands. Cleavage of Syb by
BoNT/B, D, F, and G resulted in loss of its immunoblot signals.
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t(d) Neurons were exposed to the indicated six BoNTs for 48 hrs. BoNT/E, but not other
toxins, induced axon degeneration.
(e) Neurons were exposed to BoNT/C or BoNT/E that had been pre-incubated with control
IgG, polyclonal anti-BoNT/C antibodies (1:200), or polyclonal anti-BoNT/E antibodies
(1:200) as indicated. Cells were fixed 48 hrs later for assaying axon degeneration.
(f) BoNT/C and E induced axon degeneration of both cultured rat motor neurons (upper
panel) and human motor neurons derived from embryonic stem cells (lower panel). Error
bars in all applicable panels represent SEM.
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tFigure 2. The protease domains of BoNT/C and E induce cell-autonomous degeneration of
neurons
(a) A schematic model of the three domain structures of BoNTs.
(b) LCs of BoNT/A, C, and E were expressed in neurons via lentiviral transduction. Cells
were harvested for immunoblot analysis 48 hrs later. LCs of BoNT/A, C, and E cleaved their
target SNARE proteins in neurons.
(c) LCs of BoNT/A, C, and E were expressed in neurons via lentiviral transduction. Cells
were fixed for axon degeneration analysis 96 hrs later. LCs of BoNT/C and E, but not
BoNT/A, induced axon degeneration.
(d) High-density cultured hippocampal neurons were transfected with LCs of BoNT/A, C, or
E. To facilitate cell morphology analysis, neurons were co-transfected with a vector
expressing GFP. Cells were fixed 48 hrs later and subjected to immunostaining analysis.
Expression of BoNT/C-LC and E-LC resulted in degeneration of transfected neurons,
without affecting neighboring neurons. Scale bars in all panels represent 20 μm.
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tFigure 3. Syx 1 and SNAP-25 are both required for neuron survival
(a) BoNT/C resistant (CR) mutants of Syx 1A, 1B, and Syx 2 were expressed in neurons via
lentiviral transduction. Cells were exposed to BoNT/C (0.3 nM, 12 hrs) and cell lysates were
subjected to immunoblot analysis using antibodies for Syx 1 and SNAP-25 (left panel), or
for Syx 2 (right panel). Syx 1A has a slightly lower molecular weight than Syx 1B. Cleavage
of endogenous Syx 1 by BoNT/C generated multiple degraded fragments (left panel, marked
by asterisks). Cleavage of SNAP-25 by BoNT/C generated a smaller fragment indicated by
double asterisks. Actin and Syb served as loading controls. CR mutants are resistant to
BoNT/C, and their expression did not affect cleavage of endogenous Syx 1 and SNAP-25 by
BoNT/C.
(b) Syx 1A/CR, 1B/CR, and 2/CR were expressed in neurons. Neurons were exposed to
BoNT/C and axon degeneration was analyzed.
(c) BoNT/E-resistant SNAP-25 mutant (SNAP-25/ER) was expressed in neurons. Neurons
were exposed to BoNT/E and subjected to immunoblot analysis. Cleavage of SNAP-25
generated a smaller fragment marked by an asterisk. SNAP-25/ER is resistant to BoNT/E,
and its expression did not affect cleavage of endogenous SNAP-25 by BoNT/E.
(d) WT rat SNAP-23 was expressed in neurons via lentiviral transduction (+). Neurons were
exposed to BoNT/E as indicated. WT SNAP-23 was not cleaved by nanomolar levels of
BoNT/E in neurons.
(e) SNAP-25/ER and SNAP-23 were expressed in neurons. Neurons were exposed to
BoNT/E and axon degeneration was analyzed.
(f) Neurons were exposed to 10 pM BoNT/C for the indicated times. Cell lysates were
harvested and subjected to immunoblot analysis.
(g) Neurons were exposed to 100 pM BoNT/E for the indicated times. Cell lysates were
harvested and subjected to immunoblot analysis.
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t(h) SNAP-25 in neurons was knocked down via lentiviral-mediated shRNA. The KD
efficiency was confirmed by immunoblot (left panel). Knocking down SNAP-25 did not
induce axon fragmentation (right panel), indicating that the residue levels of SNAP-25 are
still sufficient to support neuron survival. Scale bars in all panels represent 20 μm. Error bars
in all panels represent SEM.
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tFigure 4. SNAP-25 cleaved by BoNT/A has reduced capacity to tolerate additional mutations
(a) A schematic drawing of the cleavage sites for BoNT/A, C, and E on rat SNAP-25.
(b) Both full-length human SNAP-23 (hSNAP-23) and a truncation mutant lacking the last
nine amino acids (hSNAP-23-Δ9) prevented axon degeneration in the presence of BoNT/E.
(c) Schematic drawings showing mutants of SNAP-25 and their ability to support neuron
survival. SNAP-25-Δ9 is the cleavage product generated by BoNT/A. The mutation site in
SNAP-25/ER is marked in black.
(d,e) SNAP-25/ER mutant was expressed in neurons via lentiviral transduction. Neurons
were exposed to BoNT/A alone, BoNT/E alone, or exposed to both BoNT/E and BoNT/A
(BoNT/E+A). The single asterisk indicates the endogenous SNAP-25 cleaved by BoNT/E,
while the double asterisk indicates the exogenous SNAP-25/ER cleaved by BoNT/A (panel
d). When endogenous SNAP-25 was ablated by BoNT/E, cleavage of SNAP-25/ER by
BoNT/A resulted in axon degeneration (panel e). Error bars in all panels represent SEM.
Scale bars in all panels represent 20 μm.
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tFigure 5. Syx 1 and SNAP-25 act as SNARE proteins to support neuron survival
(a) Point mutations in Syx 1 (A240V,V244A) abolished the ability of Syx 1A/CR to prevent
BoNT/C-induced neurodegeneration. (b) Point mutation (M71A) within the SNARE domain
of SNAP-25 abolished the ability of SNAP-25/ER to prevent BoNT/E-induced degeneration.
(c) The sequence alignment of the layer −4 to +4 interfaces in the middle portion of the
SNARE complex containing Syx 1A, SNAP-23, and Syb. SNAP-23 contributes two helixes,
with only the N-terminus helix shown in the alignment, which contains the targeted
mutation sites. Layer-1 and 1 in Syx 1A/CR and SNAP-23 were highlighted in red and
mutated to alanines (designated as Syx 1A/CR (+1−1) and SNAP-23(+1/−1)). SNAP-23 was
used to avoid additional mutations at the BoNT/E cleavage site.
(d) Syx 1A/CR(+1−1) can prevent BoNT/C-induced axon degeneration. SNAP-23(+1−1)
can prevent BoNT/E-induced axon degeneration. However, a combination of Syx 1A/
CR(+1−1) and SNAP-23(+1−1) failed to prevent axon degeneration in the presence of both
BoNT/C and E. Error bars in all panels represent SEM. Scale bars in all panels represent 20
μm.
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tFigure 6. Syx 1/SNAP-25 can be replaced by homologous SNARE proteins to support neuron
survival
(a) A list of all known plasma membrane SNARE proteins. (b-d) WT Syx 2 (panel b), Syx 3
(panel c), and Syx 4 (panel d) were expressed in neurons via lentiviral transduction. Syx
1A/CR was co-expressed as indicated in each panel to prevent neuron death during the
incubation with BoNT/C (0.3 nM, 48 hrs). Syx 2, 3, and 4 were detected using their specific
antibodies. The Syx 2 antibody also cross-recognizes endogenous Syx 1, which is marked by
an asterisk (panel b). Hippocampal neurons do not express detectable levels of endogenous
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tSyx 2, 3, or 4. Exogenous WT Syx 2, 3, and 4 expressed via lentiviral transduction were not
cleaved by 0.3 nM BoNT/C within 48 hrs in neurons.
(e) WT Syx 2, 3, 4, and Syx 1A/CR were expressed in neurons. Neurons were exposed to
BoNT/C and axon degeneration was analyzed.
(f) Co-expressing exogenous SNAP-23 with Syx 2, 3, or 4 prevented axon degeneration
induced by BoNT/C. Expressing SNAP-23 alone failed to prevent BoNT/C-induced axon
degeneration. (g, h) A mutant BoNT/C-LC, BoNT/C-α51, which still cleaves Syx but loses
the ability to cleave SNAP-25 (panel g), was co-expressed with Syx 2, 3, or 4 in neurons via
lentiviral transduction. BoNT/C-α51 induced axon degeneration, which was prevented by
Syx 2, 3, or 4 (panel h).
(i) BoNT/C-α51 was co-expressed with Syx 2, 3, or 4 in neurons. Neurons were then
exposed to BoNT/A. BoNT/A cleaved endogenous SNAP-25 and induced axon
degeneration in neurons that express Syx 2/3/4. Scale bars in all panels represent 20 μm.
Error bars in all e panels represent SEM.
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tFigure 7. Blocking endocytosis delays BoNT/C-LC induced degeneration of neurons
(a) Neurons expressing Syx 1A/CR were exposed to BoNT/C, while neurons expressing
SNAP-25/ER were exposed to BoNT/E. Neurons exposed to BoNT/A were examined as a
control. Representative recordings (left panel) and frequencies (Feq.(Hz), right panel) of
mEPSCs are shown. Syx 1A/CR and SNAP-25/ER both failed to restore mEPSC in the
presence of toxins.
(b) Neurons were exposed to BoNT/C or E as indicated for 6 hrs. Antibody uptake
experiments were subsequently carried out using an antibody that recognizes the N-terminal
domain of synaptotagmin I (Syt IN Ab) in the high K+ solution. Syx 1A/CR and
SNAP-25/ER failed to restore Syt IN antibody uptake in neurons exposed to toxins.
(c) A secreted Gaussia luciferase (Gluc) assay was developed to monitor constitutive
exocytosis in neurons. Gluc secreted into media showed a linear increase over time and was
fully blocked by BFA.
(d) Exposure to BoNT/A, C, and E for 6 hrs did not reduce constitutive secretion of Gluc,
whereas BFA completely blocked release of Gluc.
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t(e) Neurons were exposed to BoNT/C, E, and BFA for 36 hrs. The majority of neurons
treated with BFA still remained intact, whereas BoNT/C and E have induced degeneration
of neurons.
(f) Co-transfection of a dominant negative dynamin mutant (dynamin-DN, K44A), but not
WT dynamin, with BoNT/C-LC delayed BoNT/C-LC induced degeneration of neurons. Syx
1A/CR was used as a control. GFP was co-expressed in transfected cells to monitor neuron
morphology. DsRed expression is driven by a separate promoter on the same vector as
BoNT/C-LC, thus serving as a marker for BoNT/C-LC expression (lower panel).
Percentages of survival cells 24 hrs after transfection were quantified in the right panel.
Dominant negative AP180 (AP180-C) and EPS15 (EPS15-DIII) that block clathrin-
mediated endocytosis failed to affect BoNT/C-LC induced degeneration of neurons in
parallel assays (right panel).
(g) Co-transfecting dynamin-DN (K44A) with BoNT/C-LC in Neuro-2A cells did not affect
cleavage of Syx 1 and SNAP-25 by BoNT/C-LC. Error bars in all panels represent
SEM.Scale bars in all panels represent 20 μm.
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